This week on the Caixin-Sinica Business Brief: The China-Laos railway is set to open for use in December of 2021, with plans to extend to Thailand and beyond; China considers easing capital controls to allow citizens to invest in overseas securities and insurance products; and Beijing increases its rare earth mining quotas, up 27.6% from the previous year.
In addition, we speak with Flynn Murphy of Caixin Global, who tells us about how design flaws in China’s statin drug trials led to tragic results.
Correction: The drug trials that had design flaws were for statin drugs, not COVID-19 drugs, as originally stated.
